AI, Ma Bell, and the Case for Oligopolies

“We have our factory, which is called a stage. We make a product, we color it, we title it, and we ship it out in cans.” ― Cary Grant

Chart of the Day

AI, Ma Bell, and the Case for Oligopolies

Good morning!

Amidst the bidding war that seems to have arisen for Warner Brothers Discovery, one suitor has reportedly raised antitrust concerns. The New York Post on Sunday reported that unidentified senior White House officials have expressed worries that Netflix’s bid for Warner Bros. studio and the HBO Max streaming service could have an anticompetitive effect on the content-streaming industry.

The potential for anticompetitive behavior in the tech sector has long been a concern in Washington, both in the Biden administration and in the Trump White House. It’s likely not an oversight that the January2024 FTC inquiry into the AI competitive landscape, targeting Alphabet, Amazon, Anthropic, Microsoft, and OpenAI has remained open even after Donald Trump returned to the Oval Office. The same is true for a Department of Justice antitrust investigation into Nvidia. While no charges have been filed in either investigation, neither have the probes been terminated. Despite the president’s ties to Larry Ellison, Jensen Huang, and (sometimes) Elon Musk, a significant faction within MAGA remains deeply suspicious of Silicon Valley’s influence.

Yet despite the FTC inquiry, the partnerships and deals between major AI players have only become more plentiful, interwoven, and extensive – sort of an AI Merry-Go-Round, in fact. The merry-go-round continues to get more crowded: yesterday Nvidia announced that it had taken a $2 billion stake in Synopsys (SNPS 2.32% ) to become the seventh-largest shareholder of the automated chip-design software company. Nvidia has long been a Synopsys customer, as has its rival, AMD, and yesterday’s deal is unlikely to change that. Nor will it change Nvidia’s continued relationship with Synopsys rivals like Cadence (CDNS 0.45% ), at least not for the time being.

For investors, such circularity has primarily been a concern due to fears of an AI bubble. Yet there is arguably a larger worry at stake here: one of the primary tenets of antitrust law and policy is that by impeding competition, monopolies and oligopolies also inhibit innovation. The textbook example used to illustrate the point is the Bell System, or “Ma Bell” as it was often called. Antitrust proponents point out that the early 1980s breakup of the Ma Bell monopoly was followed by innovations such as answering machines, cordless phones, long-distance carriers, and eventually mobile phones and mobile data services. 

That’s true, of course, but it’s not necessarily true that oligopolies impede innovation. After all, the monopoly that was Ma Bell famously funded Bell Labs, which gave the world the transistor, the laser, solar cells, communications satellites, information theory, the Unix operating system,  as well as the foundations for cellular technology and digital imaging/photography. Oh, and along the way, researchers at Bell Labs earned 11 Nobel Prizes. How’s that for innovation?

Some economists suggest that this was not a fluke. In their view, oligopolies and large corporations are among the few that can actually afford to fund R&D research – and with the Trump administration actively seeking to reduce government funding of basic science at leading universities, that’s an increasingly important consideration. That’s the opinion of economists like Pier Paolo Creanza, for instance, building on earlier work by the likes of Joseph Schumpeter. Creanza argues that the Great Merger Wave of 1895-1940 saw a consolidation-driven wave of innovation, as newly deep-pocketed corporations funded R&D labs in a variety of industries. 

We can already see that in some of today’s tech giants. Microsoft Research funds research in a diverse array of fields outside of traditional computing, while Alphabet’s DeepMind has branched out into areas such as neuroscience, health diagnostics, drug discovery, and advanced materials, for instance. Neither are yet regarded as the next Bell Labs, but nevertheless, each is doing important work. 

That brings us back to the Warner Bros. Discovery bidding war. Paramount, viewed as a leading contender for the acquisition (in part due to the Ellison family’s positive relationship with Trump), just happens to play a key role in antitrust history. It was the landmark 1948 Supreme Court decision in United States v Paramount Pictures, Inc. that ended the Hollywood oligopoly in which the likes of  Paramount and Warner Bros. owned not just the studios that made movies, but also the distributors and movie theaters that brought them to filmgoers. The old-school Hollywood studio system certainly had its flaws, but it would be wrong to say that it stifled innovation. After all, it birthed masterpieces like Gone With the Wind, Snow White and the Seven Dwarfs, King Kong, and The Wizard of Oz, each not just artistically important, but technologically significant.

Just ahead of yesterday’s deadline, Netflix, Paramount, and Comcast each made second-round bids for Warner Bros. Discovery. 

Share your thoughts

Should Big Tech and AI companies be subject to more antitrust scrutiny, or less? Click here to send us your response.

📧✍️Here’s what a reader commented📧✍️

Q:  Are fears of Chinese dominance in the production and refinement of critical materials overblown?

A: No. The fears are not overblown. They are very real. And this administration expanded these fears with its launch of a trade war against China. How stupid, ill advised, and ill planned. First we attack our leading trading partners Canada and Mexico. We then attack China believing we can bully it into submission. But China has a virtual monopoly on rare earths. Can this trade war really be as dumb as it is. Why wouldn’t any nation exploit this power which the US simply ignored. We declare victory by managing to get back to where we started. And at what cost? Who knows what Trump promised Xi.

Catch up with FS Insight

While stocks have felt shaky due to the November declines and also the selloff in AI stocks, we see six factors supporting a rally.

Technical

Following five straight days of gains, it’s normal to see some backing and filling, but I suspect that the first part of December should prove quite choppy into FOMC and even after, which might persist into mid-December before a strong lift back to highs into year-end.

Crypto

MSTR shifted its narrative by openly entertaining BTC sales for the first time, something previously viewed as off-limits. Despite this apparent willingness to sell BTC, investors seem to be overreacting.

News We’re Following

Breaking News

  • Stock futures rebound as bitcoin bounces, tech stocks gain CNBC

Markets and economy

  • Costco joins companies suing for refunds if Trump’s tariffs fall BBG
  • U.K. loosens bank capital demands for first time since financial crisis WSJ 

Business

  • Shopify hit with hours-long outage on Cyber Monday CNBC
  • Apple to resist India order to preload government app as political outcry builds REU
  • Blackstone, Apollo and KKR sign up to UK stress test of private credit FT 
  • Disney’s succession race enters final stage as Iger’s reign draws to end WSJ

Politics

  • Appeals court disqualifies Trump’s N.J. prosecutor pick Alina Habba, rejecting DOJ challenge CNBC 
  • Record-setting personnel issues are marring Trump’s second term POL 
  • Michael and Susan Dell to donate $6.25 billion to fund ‘Trump accounts’ for 25 million U.S. kids CNBC 

Overseas

  • ECB refuses to provide backstop for €140bn Ukraine loan FT
  • Sudan offers Russia its first naval base in Africa WSJ 

Of Interest 

  • ‘Rage bait’ named Oxford University Press word of year as outrage fuels social media traffic in 2025 AP
  • Steve Cohen, Bally’s, Genting picked to run casinos in NYC BBG
Overnight
S&P Futures
+12 point(s) (+0.18% )
overnight range:
-14 to +13 point(s)
APAC
Nikkei
0.00%
Topix
+0.08%
China SHCOMP
-0.42%
Hang Seng
+0.24%
Korea
+1.90%
Singapore
+0.26%
Australia
+0.17%
India
-0.55%
Taiwan
+0.81%
Europe
Stoxx
50 +0.57%
Stoxx
600 +0.22%
FTSE
100 +0.26%
DAX
+0.56%
CAC
40 +0.25%
Italy
+0.63%
IBEX
+0.86%
Canada
-0.90%
Mexico
-0.07%
Brazil
-0.29%
FX
Dollar Index (DXY)
+0.11% to 99.519
EUR/USD
-0.03% to 1.1606
GBP/USD
-0.15% to 1.3193
USD/JPY
-0.35% to 156.01
USD/CNY
+0.03% to 7.0697
USD/CNH
+0.07% to 7.0673
USD/CHF
-0.01% to 0.8048
USD/CAD
-0.06% to 1.4007
AUD/USD
+0.05% to 0.6547
UST Term Structure
2Y-3M Spread narrowed
-1.5bps to -26.2bps
10Y-2Y Spread widened
0.2bps to 55.6bps
30Y-10Y Spread narrowed
-0.5bps to 64.3bps
Yesterday's Recap
SPX
-0.53%
SPX Eq Wt
-0.68%
NASDAQ
100 -0.36%
NASDAQ Comp
-0.38%
Russell Midcap
-0.73%
R2k
-1.25%
R1k Value
-0.71%
R1k Growth
-0.40%
R2k Value
-0.64%
R2k Growth
-1.81%
FANG+
-0.39%
Semis
+0.19%
Software
-0.02%
Biotech
-2.69%
Regional Banks
+1.10%
SPX GICS1 Sorted
-2.35%
Indu
-1.49%
Healthcare
-1.49%
REITs
-1.39%
Comm Srvcs
-1.01%
Fin
-0.86%
SPX
-0.53%
Materials
-0.35%
Cons Staples
-0.19%
Cons Disc
+0.02%
Tech
+0.07%
Energy
+0.91%
USD HY OaS
All Sectors
+0.1bps to 344bps
All Sectors ex-Energy
-0.7bps 327bps
Cons Disc
+6.6bps to 497bps
Indu
-6.8bps to 249bps
Tech
-1.4bps to 323bps
Comm Srvcs
+1.7bps to 288bps
Materials
-2.8bps to 260bps
Energy
+1.7bps to 336bps
Fin Snr
-0.7bps to 243bps
Fin Sub
-4.0bps to 378bps
Cons Staples
+0.2bps to 428bps
Healthcare
+0.4bps to 348bps
Utes -1.1bps to 240bps *
DateTimeDescriptionEstimateLast
12/38:30 AMSep Import Price m/m0.10.3
12/39:45 AMNov F Sep F S&P Srvcs PMI5555
12/310:00 AMNov Sep ISM Srvcs PMI5252.4
12/510:00 AMDec P Oct P UMich 1yr Inf Exp4.54.5
12/510:00 AMDec P Oct P UMich Sentiment5251
12/510:00 AMSep PCE m/m0.30.3
12/510:00 AMSep Core PCE m/m0.20.23
12/510:00 AMSep PCE y/y2.82.7
12/510:00 AMSep Core PCE y/y2.82.90511
12/811:00 AMNov Sep NYFed 1yr Inf Expn/a3.24
Disclosures (show)

Get invaluable analysis of the market and stocks. Cancel at any time. Start Free Trial

Articles Read 2/2

🎁 Unlock 1 extra article by joining our Community!

You’ve reached your limit of 2 free monthly articles. Please enter your email to unlock 1 more articles.

Already have an account? Sign In

Events

Trending tickers in our research

Get invaluable analysis of the market and stocks. Cancel at any time. Start Free Trial

Articles Read 2/2

🎁 Unlock 1 extra article by joining our Community!

You’ve reached your limit of 2 free monthly articles. Please enter your email to unlock 1 more articles.

Already have an account? Sign In